BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:09 PM
 | 
Aug 03, 2009
 |  BC Extra  |  Company News

Savient down on Krystexxa complete response

Savient Pharmaceuticals Inc. (NASDAQ:SVNT) fell $2.79 (18%) to $12.80 on Monday after announcing it received a complete response letter from FDA for Krystexxa pegloticase to treat chronic refractory gout. According to the company, FDA indicated that data submitted...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >